Vanderbilt University Medical Center: Kidney Diseases Research Collaboration Renewed
October 08, 2022
October 08, 2022
NASHVILLE, Tennessee, Oct. 8 (TNSres) -- Vanderbilt University Medical Center issued the following news:
Vanderbilt University Medical Center and Bayer have agreed to continue a strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases, with the goal of accelerating the translation of innovative approaches from the laboratory to pre-clinical development.
The initial collaboration began in August 2017 with an initial plan to work to . . .
Vanderbilt University Medical Center and Bayer have agreed to continue a strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases, with the goal of accelerating the translation of innovative approaches from the laboratory to pre-clinical development.
The initial collaboration began in August 2017 with an initial plan to work to . . .